How social responsibility M&A performed in the pharmaceutical industry in Q2 2023

In value terms, social responsibility-related deal activity remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 50% in Q2 2023 versus the previous quarter.

For further understanding of GlobalData’s ESG in Sectors – Report Bundle (8 Reports), buy the report here.

This content was updated on 18 July 2023

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.

High-dose psilocybin shows promise for depression treatment

Researchers compare the effectiveness and acceptability of oral monotherapy with psychedelics for the treatment of depressive symptoms.

August 27, 2024

Could preventative care save the future of the NHS? – Pharmaceutical Technology

“The National Health Service in England is in serious trouble” according to a landmark investigation by the Rt Hon Professor the Lord Darzi of Denham.[i]

October 14, 2024

#ASH24: BTK inhibitors from AstraZeneca, Eli Lilly and BeiGene take center stage in CLL

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.